1-3 of 3
Jacob Ellefson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes

Free
Ilian A. Radichev, Lilia V. Maneva-Radicheva, Christina Amatya, Maryam Salehi, Camille Parker, Jacob Ellefson, Paul Burn, Alexei Y. Savinov
Journal: The Journal of Immunology
J Immunol (2016) 196 (4): 1495–1506.
https://doi.org/10.4049/jimmunol.1403251
Published: 15 February 2016
View articletitled, Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes
Open the PDF for Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes in another window
Add to Citation Manager for Loss of Peripheral Protection in Pancreatic Islets by Proteolysis-Driven Impairment of VTCN1 (B7-H4) Presentation Is Associated with the Development of Autoimmune Diabetes
Includes: Supplementary data
Journal Articles

Loss of peripheral protection in pancreatic islets by proteolysis-driven impairment of VTCN1 (B7-H4) presentation is associated with the development of autoimmune diabetes (BA4P.132)

Free
Ilian Radichev, Lilia Maneva-Radicheva, Christina Amatya, Maryam Salehi, Jacob Ellefson, Alexei Savinov
Journal: The Journal of Immunology
J Immunol (2015) 194 (1_Supplement): 47.12.
https://doi.org/10.4049/jimmunol.194.Supp.47.12
Published: 01 May 2015
View articletitled, Loss of peripheral protection in pancreatic islets by proteolysis-driven impairment of VTCN1 (B7-H4) presentation is associated with the development of autoimmune diabetes (BA4P.132)
Add to Citation Manager for Loss of peripheral protection in pancreatic islets by proteolysis-driven impairment of VTCN1 (B7-H4) presentation is associated with the development of autoimmune diabetes (BA4P.132)
Journal Articles

Nardilysin-dependent proteolysis of cell-associated VTCN1: A novel pathway and biomarker of type 1 diabetes development. (P4117)

Free
Alexei Savinov, Ilian Radichev, Lilia Maneva-Radicheva, Christina Amatya, Camille Parker, Jacob Ellefson, Clive Wasserfall, Mark Atkinson, Paul Burn
Journal: The Journal of Immunology
J Immunol (2013) 190 (1_Supplement): 133.12.
https://doi.org/10.4049/jimmunol.190.Supp.133.12
Published: 01 May 2013
View articletitled, Nardilysin-dependent proteolysis of cell-associated VTCN1: A novel pathway and biomarker of type 1 diabetes development. (P4117)
Add to Citation Manager for Nardilysin-dependent proteolysis of cell-associated VTCN1: A novel pathway and biomarker of type 1 diabetes development. (P4117)